Recurrent outbreaks of mumps in Lothian and the impact of waning immunity.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
18 06 2020
Historique:
pubmed: 4 7 2020
medline: 31 10 2020
entrez: 4 7 2020
Statut: epublish

Résumé

Another large outbreak of mumps occurred in Lothian from October 2017, which coincided with the commencement of the higher education term. During this period 324 cases were notified, most of whom were aged 18-22 years old. Although previous outbreaks had a focus in student populations, 43% of current cases reported that they were not a student. There has been increases in private student housing where students from all universities live, which may have contributed to the wide spread of the outbreak and complicated outbreak control. Information on vaccination status was available for 244 cases (75%), of whom the majority (75.8%) reported having two MMR doses. To investigate potential waning vaccine immunity the mean length of time since last mumps containing vaccine was calculated as 14.3 years. The outbreak was declared over in May 2018 after case numbers returned to background levels. This outbreak highlighted that mumps outbreaks occur cyclically coinciding with new cohorts of susceptible students entering the Lothian population. The lessons from this outbreak are to encourage students to have two MMR doses and also be prepared for mumps outbreaks in the near future. In future outbreaks the utility of a third MMR for outbreak control could be examined.

Identifiants

pubmed: 32616093
doi: 10.1017/S0950268820001296
pii: S0950268820001296
pmc: PMC7355216
doi:

Substances chimiques

Measles-Mumps-Rubella Vaccine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e131

Références

Clin Infect Dis. 2008 Dec 1;47(11):1458-67
pubmed: 18959494
Br J Gen Pract. 2006 Jul;56(528):526-9
pubmed: 16834879
Front Physiol. 2017 Apr 25;8:233
pubmed: 28487657
Pediatrics. 2012 Dec;130(6):e1567-74
pubmed: 23129075
Clin Infect Dis. 2019 May 2;68(10):1684-1690
pubmed: 30204850
N Engl J Med. 2017 Sep 7;377(10):947-956
pubmed: 28877026
MMWR Morb Mortal Wkly Rep. 2018 Jul 27;67(29):793-797
pubmed: 30048422
Sci Transl Med. 2018 Mar 21;10(433):
pubmed: 29563321
Epidemiol Infect. 1987 Aug;99(1):65-84
pubmed: 3609175
J Pediatric Infect Dis Soc. 2018 May 15;7(2):91-92
pubmed: 29718326
Vaccine. 2019 Sep 3;37(37):5614-5624
pubmed: 31402236
Emerg Infect Dis. 2013;19(9):1411-7
pubmed: 23965729
Epidemiol Infect. 2018 Apr;146(6):741-746
pubmed: 29564994
Euro Surveill. 2016;21(10):30156
pubmed: 26987576
Arch Virol. 2018 Nov;163(11):3059-3064
pubmed: 30078131
Epidemiol Infect. 2017 Nov;145(15):3219-3225
pubmed: 28903791

Auteurs

C J Waugh (CJ)

NHS National Services Scotland, Edinburgh, UK.

K Templeton (K)

NHS Lothian, Edinburgh, UK.

J Stevenson (J)

NHS Lothian, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH